Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer
International Journal of Clinical Oncology · 2024
DOI: 10.1007/s10147-024-02634-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Hideo Shigematsu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3-Kasumi, Minami-Ku, Hiroshima, 734…. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphocytes, Tumor-Infiltrating, Nomograms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hiroshima University.
Abstract (Originalsprache)
Background
Tumor-infiltrating lymphocytes–ultrasonography (TILs–US) score is used to predict lymphocyte-predominant breast cancer (LPBC) in surgical specimens. We aimed to compare diagnostic performance of TILs–US score for predicting pathological complete response (pCR) with that of LPBC in biopsy specimens.
Methods
TILs ≥ 50% in biopsy specimens was defined as biopsy–LPBC, and TILs–US score ≥ 4 was categorized as TILs–US score-high. Basic nomogram for pCR was developed using stepwise logistic regression based on the smallest Akaike Information Criterion, and biopsy–LPBC and TILs–US score nomograms were developed by integrating biopsy–LPBC or TILs–US scores into a basic nomogram. The diagnostic performance of the nomograms for pCR was compared using area under the curve (AUC), categorical net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
Results
This retrospective study evaluated 118 patients with breast cancer, including 33 (28.0%) with biopsy–LPBC, 52 (44.1%) with TILs–US score-high, with 34 (28.8%) achieving pCR. The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and AUC for predicting pCR were 0.53, 0.82, 2.96, 0.57, and 0.68, respectively, for biopsy–LPBC, and 0.76, 0.69, 2.47, 0.34, and 0.73, respectively, for TILs–US score. The biopsy–LPBC nomogram showed significant improvements in categorical NRI ( p = 0.023) and IDI ( p = 0.007) but not in AUC ( p = 0.25), compared with the basic nomogram. The TILs–US nomogram exhibited significant improvements in AUC ( p = 0.039), categorical NRI ( p = 0.010), and IDI ( p < 0.001).
Conclusions
The TILs–US score may serve as a novel marker for prediction of pCR in patients with breast cancer. An external validation study is warranted to confirm our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3-Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan. shigematu1330@yahoo.co.jp.
- Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, 734-8551, Japan.
- Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3-Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.
- Department of Breast Surgery, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, 731-0293, Japan.
- Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, 734-8551, Japan.
Förderung
- Hiroshima University
Zitieren
APA
Shigematsu, H., Fukui, K., Kanou, A., Yokoyama, E., Tanaka, M., Fujimoto, M., Suzuki, K., Ikejiri, H., Amioka, A., Hiraoka, E., Sasada, S., Emi, A., Nakagiri, T., Arihiro, K., & Okada, M. (2024). Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02634-9
Vancouver
Shigematsu H, Fukui K, Kanou A, Yokoyama E, Tanaka M, Fujimoto M, et al. Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02634-9
BibTeX
@article{Shigematsu2024,
author = {Shigematsu, Hideo and Fukui, Kayo and Kanou, Akiko and Yokoyama, Erika and Tanaka, Makiko and Fujimoto, Mutsumi and Suzuki, Kanako and Ikejiri, Haruka and Amioka, Ai and Hiraoka, Emiko and Sasada, Shinsuke and Emi, Akiko and Nakagiri, Tetsuya and Arihiro, Koji and Okada, Morihito},
title = {Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer},
journal = {International Journal of Clinical Oncology},
year = {2024},
doi = {10.1007/s10147-024-02634-9}
}
EUVIMED